Prenatal cytogenetic diagnosis: results obtained in the specialized laboratory of Clínica Universitaria Colombia from 2013 to 2019

J Matern Fetal Neonatal Med. 2022 Dec;35(25):7430-7437. doi: 10.1080/14767058.2021.1949450. Epub 2021 Sep 1.

Abstract

Objective: Prenatal cytogenetic evaluation is a key tool for identifying alterations in pregnant women with high risk for fetal chromosomal abnormalities (CA). In Colombia, there are not large-scale reports about the prevalence and pattern of CA in prenatal cytogenetic analysis.

Method: A descriptive study was performed from registers of prenatal cytogenetic analysis on amniotic fluid (AF), chorionic villus biopsy (CVS), and fetal blood (FB) samples sent to the specialized laboratory of the Clínica Universitaria Colombia between 2013 and 2019.

Results: The prevalence of CA was 20.9%. The trisomies 21, 18, 13, and monosomy X were the most frequent aneuploidies, and the derivative chromosomes were the most frequent structural abnormalities. Although the rate of CA was higher in women over the age of 35 years old; monosomy X, unbalanced rearrangements, and microduplications were associated with the group of women under the age of 35 (p < .05). Trisomies 21 and 18 were the most common aneuploidies identified by FISH and were found to be altered in 52% of the aCGH studies. Ultrasonographic markers associated with CA were the most frequent clinical indication.

Conclusion: In Colombia, the invasive prenatal cytogenetic analysis continues being an important diagnostic tool available for pregnant women with high risk for fetal CA.

Keywords: FISH and aCGH; Invasive prenatal cytogenetic analysis; chromosomal abnormalities; karyotype.

MeSH terms

  • Aneuploidy
  • Chromosome Aberrations
  • Colombia / epidemiology
  • Cytogenetic Analysis
  • Down Syndrome* / diagnosis
  • Down Syndrome* / epidemiology
  • Down Syndrome* / genetics
  • Female
  • Humans
  • Pregnancy
  • Prenatal Diagnosis / methods
  • Trisomy / diagnosis
  • Turner Syndrome*